45. Egyptian International Pharmaceutical Industries Company (EIPICO)

Sector: Pharmaceuticals

Chairman and Managing Director: Ahmed Kelani

Market Value: $130 million

Sales: $109 million

Profits: $17 million

Assets: $208 million

EIPICO was established in 1980. In 2023, its products accounted for 25% of Egyptian pharmaceutical exports, covering 78 countries worldwide. In 2023, it recorded total sales of $109 million, a growth of 32% compared to 2022. EIPICO is planning to open its EIPICO 3 factory in Q2 2024, which will be the first factory in Egypt and the Middle East to produce biosimilars and its preparations, at an investment of $100 million.

@media only screen and (max-width: 600px) { .custom_line_height{ line-height: 40px !important; } }

45. Egyptian International Pharmaceutical Industries Company (EIPICO)